Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 386

1.

Two-year safety evaluation of a biodegradable polymer sirolimus-eluting stent with increased drug elution and polymer absorption kinetics in complex patient and lesion cohort.

Jia S, Guan C, Yuan J, Cao X, Qin L, Li Y, Li Z, Nie S, Hou S, Zhang M, Brouwer M, Suryapranata H, Xu B, Gao R.

Catheter Cardiovasc Interv. 2019 Apr 16. doi: 10.1002/ccd.28288. [Epub ahead of print]

PMID:
30990245
2.

Ticagrelor in the prevention of coronary and non-coronary atherothrombotic events: A comprehensive meta-analysis of 10 randomized trials.

Verdoia M, Kedhi E, Suryapranata H, De Luca G.

Atherosclerosis. 2019 Feb 25;284:136-147. doi: 10.1016/j.atherosclerosis.2019.02.011. [Epub ahead of print]

PMID:
30884417
3.

Three-year clinical outcomes after dual-therapy COMBO stent placement: Insights from the REMEDEE registry.

Kalkman DN, Kerkmeijer LS, Woudstra P, Menown IBA, Suryapranata H, den Heijer P, Iñiguez A, van 't Hof AWJ, Erglis A, Arkenbout KE, Muller P, Koch KT, Tijssen JG, Beijk MAM, de Winter RJ.

Catheter Cardiovasc Interv. 2018 Dec 18. doi: 10.1002/ccd.28047. [Epub ahead of print]

PMID:
30565371
4.

Use, timing and outcome of coronary angiography in patients with high-risk non-ST-segment elevation acute coronary syndrome in daily clinical practice: insights from a 'real world' prospective registry.

Badings EA, Hermanides RS, Van Der Sluis A, Dambrink JHE, Gosselink ATM, Kedhi E, Ottervanger JP, Roolvink V, Remkes WS, Van't Riet E, Suryapranata H, Van't Hof AWJ.

Neth Heart J. 2019 Feb;27(2):73-80. doi: 10.1007/s12471-018-1212-3.

5.

Prevalence and predictors of high-on treatment platelet reactivity during prasugrel treatment in patients with acute coronary syndrome undergoing stent implantation.

Verdoia M, Pergolini P, Nardin M, Rolla R, Barbieri L, Marino P, Carriero A, Suryapranata H, De Luca G; Novara Atherosclerosis Study Group.

J Cardiol. 2019 Mar;73(3):198-203. doi: 10.1016/j.jjcc.2018.10.005. Epub 2018 Dec 3.

PMID:
30522897
6.

Use of Metformin and Platelet Reactivity in Diabetic Patients Treated with Dual Antiplatelet Therapy.

Verdoia M, Pergolini P, Rolla R, Ceccon C, Caputo M, Aimaretti G, Suryapranata H, De Luca G.

Exp Clin Endocrinol Diabetes. 2018 Nov 29. doi: 10.1055/a-0787-1382. [Epub ahead of print]

PMID:
30497083
7.

Impact of immature platelet fraction on platelet reactivity during prasugrel maintenance treatment.

Verdoia M, Pergolini P, Rolla R, Suryapranata H, Kedhi E, De Luca G on behalf of the Novara Atherosclerosis Study Group (NAS).

Platelets. 2018 Nov 13:1-8. doi: 10.1080/09537104.2018.1535707. [Epub ahead of print]

PMID:
30422043
8.

Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome.

Schwartz GG, Steg PG, Szarek M, Bhatt DL, Bittner VA, Diaz R, Edelberg JM, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Lecorps G, Mahaffey KW, Moryusef A, Pordy R, Quintero K, Roe MT, Sasiela WJ, Tamby JF, Tricoci P, White HD, Zeiher AM; ODYSSEY OUTCOMES Committees and Investigators.

N Engl J Med. 2018 Nov 29;379(22):2097-2107. doi: 10.1056/NEJMoa1801174. Epub 2018 Nov 7.

PMID:
30403574
9.

Impact of increasing dose of intracoronary adenosine on peak hyperemia duration during fractional flow reserve assessment.

Verdoia M, Erbetta R, Sagazio E, Barbieri L, Negro F, Suryapranata H, Kedhi E, De Luca G; Novara Atherosclerosis Study Group (NAS).

Int J Cardiol. 2019 Jun 1;284:16-21. doi: 10.1016/j.ijcard.2018.09.088. Epub 2018 Oct 2.

PMID:
30293665
10.

Feasibility and Outcomes of Transcatheter Aortic Valve Implantation Using the Left Axillary Artery as Primary Access Site.

van der Wulp K, Verkroost MWA, van Wely MH, Gehlmann HR, Van Garsse LAFM, Noyez L, Brouwer MA, Kievit PC, De Boer MJ, Suryapranata H, Morshuis WJ, van Royen N.

Ann Thorac Surg. 2019 Feb;107(2):546-552. doi: 10.1016/j.athoracsur.2018.07.093. Epub 2018 Oct 4.

PMID:
30292844
11.

1-Year Clinical Outcomes of All-Comer Patients Treated With the Dual-Therapy COMBO Stent: Primary Results of the COMBO Collaboration.

de Winter RJ, Chandrasekhar J, Kalkman DN, Aquino MB, Woudstra P, Beijk MA, Sartori S, Baber U, Tijssen JG, Koch KT, Dangas GD, Colombo A, Mehran R; MASCOT; REMEDEE Registry Investigators.

JACC Cardiovasc Interv. 2018 Oct 8;11(19):1969-1978. doi: 10.1016/j.jcin.2018.04.038.

PMID:
30286855
12.

Impact of vascular access on the development of contrast induced nephropathy in patients undergoing coronary angiography and/or percutaneous coronary intervention.

Barbieri L, Verdoia M, Suryapranata H, De Luca G; Novara Atherosclerosis Study Group (NAS).

Int J Cardiol. 2019 Jan 15;275:48-52. doi: 10.1016/j.ijcard.2018.08.026. Epub 2018 Aug 10.

PMID:
30274753
13.

A multi-site coronary sampling study on CRP in non-STEMI: Novel insights into the inflammatory process in acute coronary syndromes.

Damen SAJ, Cramer GE, Dieker HJ, Gehlmann H, Aengevaeren WRM, Oude Ophuis TJM, Fokkert MJ, Dikkeschei LD, Vroemen WHM, Verheugt FWA, Brouwer MA, Suryapranata H.

Atherosclerosis. 2018 Nov;278:117-123. doi: 10.1016/j.atherosclerosis.2018.09.024. Epub 2018 Sep 19.

14.

Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial.

Vranckx P, Valgimigli M, Jüni P, Hamm C, Steg PG, Heg D, van Es GA, McFadden EP, Onuma Y, van Meijeren C, Chichareon P, Benit E, Möllmann H, Janssens L, Ferrario M, Moschovitis A, Zurakowski A, Dominici M, Van Geuns RJ, Huber K, Slagboom T, Serruys PW, Windecker S; GLOBAL LEADERS Investigators.

Lancet. 2018 Sep 15;392(10151):940-949. doi: 10.1016/S0140-6736(18)31858-0. Epub 2018 Aug 27.

PMID:
30166073
15.

Corrigendum to "Duration of dual antiplatelet therapy and outcome in patients with acute coronary syndrome undergoing percutaneous revascularization: A meta-analysis of 11 randomized trials" [Int. J. Cardiol. 264 (2018) 30-38].

Verdoia M, Kedhi E, Ceccon C, Suryapranata H, De Luca G.

Int J Cardiol. 2018 Nov 15;271:407. doi: 10.1016/j.ijcard.2018.06.016. Epub 2018 Aug 23. No abstract available.

PMID:
30146247
16.

Duration of dual antiplatelet therapy and outcome in patients with acute coronary syndrome undergoing percutaneous revascularization: A meta-analysis of 11 randomized trials.

Verdoia M, Kedhi E, Ceccon C, Suryapranata H, De Luca G.

Int J Cardiol. 2018 Aug 1;264:30-38. doi: 10.1016/j.ijcard.2018.02.095. Erratum in: Int J Cardiol. 2018 Nov 15;271:407.

PMID:
29776573
17.

Percutaneous Versus Surgical Revascularization for Left Main or Multivessel Coronary Artery Disease: Results From a Large-Scale Meta-Analysis in the Era of Drug-Eluting Stents.

Verdoia M, Barbieri L, Kedhi E, Suryapranata H, De Luca G.

Angiology. 2018 Oct;69(9):812-824. doi: 10.1177/0003319718768656. Epub 2018 Apr 16.

PMID:
29661004
18.

Vitamin D deficiency and periprocedural myocardial infarction in patients undergoing percutaneous coronary interventions.

Verdoia M, Ceccon C, Nardin M, Suryapranata H, De Luca G; Novara Atherosclerosis Study Group (NAS).

Cardiovasc Revasc Med. 2018 Oct;19(7 Pt A):744-750. doi: 10.1016/j.carrev.2018.03.002. Epub 2018 Mar 4.

PMID:
29656938
19.

Comparison of Outcomes and Intervention Among Patients With Non-ST-Segment Elevation Acute Myocardial Infarction of Those With a Left Circumflex Versus Those With a Non-Left Circumflex-Related Coronary Artery (From the ELISA-3 Trial).

Badings EA, Hermanides RS, The SHK, Dambrink JE, Rasoul S, Van Wijngaarden J, Van 't Riet E, Kolkman E, Remkes WS, Tjeerdsma G, Van Der Wielen MLJ, Lok DJA, Suryapranata H, Van 't Hof AWJ.

Am J Cardiol. 2018 May 15;121(10):1123-1128. doi: 10.1016/j.amjcard.2018.01.031. Epub 2018 Feb 21.

PMID:
29606324
20.

Impact of pre-procedural dual antiplatelet therapy on periprocedural myocardial infarction in patients undergoing percutaneous coronary interventions with adjunctive tirofiban.

Verdoia M, Pergolini P, Barbieri L, Rolla R, Nardin M, Negro F, Suryapranata H, De Luca G; Novara Atherosclerosis Study Group (NAS).

Thromb Res. 2018 Apr;164:17-23. doi: 10.1016/j.thromres.2018.02.008. Epub 2018 Feb 15.

PMID:
29475177

Supplemental Content

Loading ...
Support Center